The Globe and Mail | Novartis buys Chinook for US$3.2-billion, latest in string of big exits for Canadian biotechs

Bloom Burton Equity Research Analyst Antonia Borovina comments in The Globe and Mail regarding Chinook Therapeutics’ (NASDAQ:KDNY) sale to Novartis.

The company was chosen as a 2023 Biotechnology Top Idea by Bloom Burton Equity Research